Seeing Is Believing
TVTX is currently covered by 13 analysts with an average price target of $43.08. This is a potential upside of $15.77 (57.74%) from yesterday's end of day stock price of $27.31.
Travere Therapeutics's activity chart (see below) currently has 115 price targets and 133 ratings on display. The stock rating distribution of TVTX is 89.06% BUY and 10.94% HOLD.
Analysts average stock forecasts to be materialized ratio is 34.73% with an average time for these price targets to be met of 138.8 days.
Highest price target for TVTX is $47, Lowest price target is $20, average price target is $33.42.
Most recent stock forecast was given by GREG HARRISON from SCOTIABANK on 07-Aug-2025.
Currently out of the existing stock ratings of TVTX, 57 are a BUY (89.06%), 7 are a HOLD (10.94%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$31
$9.36 (43.25%)
$31
1 months 3 days ago
(07-Aug-2025)
4/12 (33.33%)
$14.09 (83.32%)
77
Buy
$32
$10.36 (47.87%)
$30
1 months 3 days ago
(07-Aug-2025)
9/16 (56.25%)
$15.09 (89.24%)
198
Buy
$30
$8.36 (38.63%)
$22
2 months 30 days ago
(11-Jun-2025)
12/20 (60%)
$15.48 (106.61%)
246
Hold
$23
$1.36 (6.28%)
$10
4 months 8 days ago
(02-May-2025)
5/6 (83.33%)
$1.85 (8.75%)
141
Buy
$47
$25.36 (117.19%)
$41
4 months 27 days ago
(14-Apr-2025)
2/8 (25%)
$32.17 (216.93%)
264
What is TVTX (Travere Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on TVTX (Travere Therapeutics) with a proven track record?
Which analyst has the most public recommendations on TVTX (Travere Therapeutics)?
Which analyst is the currently most bullish on TVTX (Travere Therapeutics)?
Which analyst is the currently most reserved on TVTX (Travere Therapeutics)?